Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic Giuseppe MagroStefania BaronePaola Valentino Original Communication 13 October 2022 Pages: 595 - 600
New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review Yan TereshkoGian Luigi GigliMariarosaria Valente Short Commentary 09 November 2022 Pages: 601 - 609
SARS-CoV-2 in patients with Friedreich ataxia Megan M. ShenLayne N. RoddenDavid R. Lynch Letter to the Editors 11 October 2022 Pages: 610 - 613
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report Assunta BiancoFrancesca ColòMassimiliano Mirabella Letter to the Editors 12 October 2022 Pages: 614 - 617
Preventing falls: the use of machine learning for the prediction of future falls in individuals without history of fall Ioannis BargiotasDanping WangPierre-Paul Vidal Review Open access 11 July 2022 Pages: 618 - 631
Capturing nystagmus in the emergency room: posterior circulation stroke versus acute vestibular neuritis B. NhamG. AkdalM. S. Welgampola Original Communication Open access 18 July 2022 Pages: 632 - 641
Different approaches to test orientation of self in space: comparison of a 2D pen-and-paper test and a 3D real-world pointing task J. GerbT. BrandtM. Dieterich Original Communication Open access 07 November 2022 Pages: 642 - 650
Prevalence, risk factors, and clinical outcomes of remote intracerebral hemorrhage after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis Lingling QiuFangwang FuZicheng Cheng Review 05 October 2022 Pages: 651 - 661
Comparative effect of stenting plus medical therapy vs medical therapy alone on the risk of stroke and death in patients with symptomatic intracranial stenosis: a systematic review and meta-analysis Xin WuJiaxuan LiZhong Wang Review Open access 27 October 2022 Pages: 662 - 672
RCVS: by clinicians for clinicians—a narrative review Deborah Katharina ErhartAlbert Christian LudolphKatharina Althaus Review Open access 28 October 2022 Pages: 673 - 688
Preventive treatment of refractory chronic cluster headache: systematic review and meta-analysis Javier A. MembrillaJavier RoaJavier Díaz-de-Terán Review 31 October 2022 Pages: 689 - 710
Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses Susana López-OrtizSimone ListaAlejandro Santos-Lozano Review 07 November 2022 Pages: 711 - 725
A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis Robert SimpsonStephanie PosaMark Bayley Review Open access 09 November 2022 Pages: 726 - 745
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases Sephira RymanAndrei A. VakhtinHenry C. Lin Review Open access 10 November 2022 Pages: 746 - 758
Retina thickness in clinically affected and unaffected eyes in patients with aquaporin-4 immunoglobulin G antibody seropositive neuromyelitis optica spectrum disorders: a systematic review and meta-analysis Lele HuangYujie WangRuijun Zhang Review 10 November 2022 Pages: 759 - 768
Isolated transient vertigo due to TIA: challenge for diagnosis and therapy Kai YaoHeng-bing Zu Review 12 November 2022 Pages: 769 - 779
Locus coeruleus degeneration and cerebellar gray matter changes in essential tremor Dayao LvCheng ZhouYaping Yan Original Communication 04 October 2022 Pages: 780 - 787
Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin Harald HefterDietmar RosenthalSara Samadzadeh Original Communication Open access 05 October 2022 Pages: 788 - 796
Dystonia management across Europe within ERN-RND: current state and future challenges Liesanne M. CentenDavid PinterSylvia Boesch Original Communication Open access 06 October 2022 Pages: 797 - 809
NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis Paolo PreziosaElisabetta PaganiMassimo Filippi Original Communication 06 October 2022 Pages: 810 - 823
Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis Alexander WuschekMatthias BussasMark Mühlau Original Communication Open access 07 October 2022 Pages: 824 - 830
Video augmented mirror therapy for upper extremity rehabilitation after stroke: a randomized controlled trial Hyunjin KimJunghyun KimChangho Song Original Communication 10 October 2022 Pages: 831 - 842
Efficacy and safety of very early mobilization after thrombolysis in acute ischemic stroke: a randomized clinical trial Jorge Motta AnjosMansueto Gomes NetoAndre Rodrigues Duraes Original Communication 11 October 2022 Pages: 843 - 850
The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes Mark ThallerVictoria HomerAlexandra J. Sinclair Original Communication Open access 15 October 2022 Pages: 851 - 863
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease: a study of linked Swedish National Registries (2002–2019) Hannah FurbySuzanne MooreÅsa Petersén Original Communication Open access 18 October 2022 Pages: 864 - 876
Factors predicting disease progression in C9ORF72 ALS patients Jessica MandrioliElisabetta ZucchiAndrea Calvo Original Communication 25 October 2022 Pages: 877 - 890
Thrombolysis in central retinal artery occlusion: a retrospective observational study Florian Philipp RaberFlorian Vincent GmeinerKatharina Althaus Original Communication Open access 28 October 2022 Pages: 891 - 897
Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis Eleonora ColomboBarbara PolettiNicola Ticozzi Original Communication Open access 29 October 2022 Pages: 898 - 908
The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study Martin KrennMerve SenerHakan Cetin Original Communication Open access 29 October 2022 Pages: 909 - 916
Lesion follows function: video-oculography compared with MRI to diagnose internuclear ophthalmoplegia in patients with multiple sclerosis Rawan OmaryChristopher J. BockischKonrad P. Weber Original Communication Open access 31 October 2022 Pages: 917 - 924
Clinical, muscle imaging, and genetic characteristics of dystrophinopathies with deep-intronic DMD variants Zhiying XieChengyue SunYun Yuan Original Communication 02 November 2022 Pages: 925 - 937
Noisy galvanic vestibular stimulation improves vestibular perception in bilateral vestibulopathy Max WuehrJosefine EderKlaus Jahn Original Communication Open access 02 November 2022 Pages: 938 - 943
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors Holger HengelPeter MartusLudger Schöls Original Communication Open access 02 November 2022 Pages: 944 - 952
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study Antonio CanosaAlessio MartinoAdriano Chiò Original Communication Open access 02 November 2022 Pages: 953 - 959
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies Laura FiondaAntonio LaulettaMatteo Garibaldi Original Communication Open access 03 November 2022 Pages: 960 - 974
Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study Alexander BalceracKevin BihanNicolas Weiss Original Communication 03 November 2022 Pages: 975 - 985
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study Claudia AltamuraR. OrnelloF. Vernieri Original Communication 03 November 2022 Pages: 986 - 994
Effect of transcutaneous auricular vagus nerve stimulation on post-stroke dysphagia Ying WangYingxi HeLingchuan Niu Original Communication 03 November 2022 Pages: 995 - 1003
Clinical and paraclinical features of small fiber neuropathy in Sjögren’s syndrome Tabea SeeligerHenrike Neelke DreyerThomas Skripuletz Original Communication Open access 04 November 2022 Pages: 1004 - 1010
Health-related quality of life in Japanese patients with multiple sclerosis Masaaki NiinoShoko FukumotoNobuhiro Mifune Original Communication 05 November 2022 Pages: 1011 - 1018
Neuropsychological assessment through Coma Recovery Scale-Revised and Coma/Near Coma Scale in a sample of pediatric patients with disorder of consciousness Susanna FrigerioErika MolteniSandra Strazzer Original Communication Open access 05 November 2022 Pages: 1019 - 1029
Vitamin D genetic risk scores in multiple sclerosis Ashvin KuriNicola VickaryousRuth Dobson Original Communication Open access 05 November 2022 Pages: 1030 - 1035
Sporadic Creutzfeldt–Jakob Disease in the young (50 and below): 10-year review of United Kingdom surveillance Johnny TamJohn CentolaSuvankar Pal Original Communication Open access 05 November 2022 Pages: 1036 - 1046
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative Alessandro Pasquale De RosaFabrizio Espositothe INNI Network Original Communication Open access 09 November 2022 Pages: 1047 - 1066
Diplopia: characteristics and etiologic distribution in a referral-based university hospital Hyun-Jae KimHyo-Jung KimJi-Soo Kim Original Communication 10 November 2022 Pages: 1067 - 1075
Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study Harry L. HébertAbirami VeluchamyBlair H. Smith Original Communication Open access 10 November 2022 Pages: 1076 - 1094
Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives Penny PenningtonBianca Weinstock-GuttmanRobert Zivadinov Original Communication 14 November 2022 Pages: 1095 - 1119
Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives Penny PenningtonBianca Weinstock-GuttmanRobert Zivadinov Correction 27 December 2022 Pages: 1120 - 1126
Brain structural abnormalities and cognitive changes in a patient with 17q21.31 microduplication and early onset dementia: a case report Michela LeocadiElisa CanuMassimo Filippi Short Commentary 15 October 2022 Pages: 1127 - 1134
Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD) Jonathan A. GernertRebecca WickleinJoachim Havla Short Commentary Open access 16 October 2022 Pages: 1135 - 1140